Movatterモバイル変換


[0]ホーム

URL:


SG11201806985WA - Methods and reagents for prevention and/or treatment of infection - Google Patents

Methods and reagents for prevention and/or treatment of infection

Info

Publication number
SG11201806985WA
SG11201806985WASG11201806985WASG11201806985WASG11201806985WASG 11201806985W ASG11201806985W ASG 11201806985WASG 11201806985W ASG11201806985W ASG 11201806985WASG 11201806985W ASG11201806985W ASG 11201806985WASG 11201806985W ASG11201806985W ASG 11201806985WA
Authority
SG
Singapore
Prior art keywords
hospitalet
international
reynals
idibell
llobregat
Prior art date
Application number
SG11201806985WA
Inventor
Mendiluce Rafael Mañez
Vallés Cristina Costa
Cruz Magdiel Pérez
Gil Daniel Bello
Original Assignee
Inst Dinvestigacio Biomedica De Bellvitge Idibell
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Dinvestigacio Biomedica De Bellvitge IdibellfiledCriticalInst Dinvestigacio Biomedica De Bellvitge Idibell
Publication of SG11201806985WApublicationCriticalpatent/SG11201806985WA/en

Links

Classifications

Landscapes

Abstract

INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property , Organization 111111110111101110101H OH 110101011010111IIH H IDIOM MI International Bureau .. .... ..Yejd (10) International Publication Number (43) International Publication Date ..... .....!;,' WO 2016/026981 Al 25 February 2016 (25.02.2016) WIPO I PCT (51) International Patent Classification: cio Biomedica De Bellvitge (idibell), Hospital Duran i A61K 45/06 (2006.01) A61P 31/04 (2006.01) Reynals, 3' planta Gran Via de l'Hospitalet, 199, 08908 A61K 38/14 (2006.01) A61K 31/702 (2006.01) Hospitalet de Llobregat (ES). A61K 31/7016 (2006.01) A61K 31/785 (2006.01) (74) Agent: ALCONADA RODRIGUEZ, Agustin; ABG Pat- A61K 31/7028 (2006.01) entes, S.L., Avenida de Burgos, 16D, Edificio Euromor, E- (21) International Application Number: 28036 Madrid (ES). PCT/EP2015/069334 (81) Designated States (unless otherwise indicated, for every (22) International Filing Date: kind of national protection available): AE, AG, AL, AM, 24 August 2015 (24.08.2015) AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, (25) Filing Language: English DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, (26) Publication Language: English HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, (30) Priority Data: MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, 14382324.3 22 August 2014 (22.08.2014) EP PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (71) Applicant: INSTITUT D'INVESTIGACIO BIO- SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, MEDICA DE BELLVITGE (IDIBELL) [ES/ES]; Hos- TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. pital Duran i Reynals, 3' planta Gran Via de l'Hospitalet, (84) Designated States (unless otherwise indicated, for every 199, 08908 Hospitalet de Llobregat (ES). kind of regional protection available): ARIPO (BW, GH, — (72) Inventors: MASEZ MENDILUCE, Rafael; Institut D'in- GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, 5Z, TZ, ZM, ZW), Eurasian AZ, BY, KG, KZ, RU, — vestigacio Biomedica De Bellvitge (idibell), Hospital Dur- UG, (AM, _ TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, an i Reynals, 3' planta Gran Via de l'Hospitalet, 199, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, 08908 Hospitalet de Llobregat (ES). COSTA VALLES, Cristina; Institut D'investigacio Biomedica De Bellvitge LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, (idibell), Hospital Duran i Reynals, 3' Gran Via de 1 SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, planta 'Hospitalet, GW, KM, ML, MR, NE, SN, TD, TG). 199, 08908 Hospitalet de Llobregat (ES). = PEREZ CRUZ, Magdiel; Institut D'investigaciO Bio- Published: medica De Bellvitge (idibell), Hospital Duran i Reynals, 3' Gran Via de l'Hospitalet, 199, 08908 Hospitalet de with international search report (Art. 21(3)) planta Llobregat (ES). BELLO GIL, Daniel; Institut D'investiga- - = = = = = = = 1-1 Il GC C:7 ei © 1-1 C:::: ) (54) Title: METHODS AND REAGENTS FOR PREVENTION AND/OR TREATMENT OF INFECTION ei 0 (57) : The present invention relates to the field of therapeutics and, more in particular, to agents and compositions for the ,-t prevention and/or treatment of infection caused by bacteria of the gastrointestinal tract in a subject, said agents and compositions be - .,- ing based on agents comprising a terminal ct-galactosyl moiety.
SG11201806985WA2014-08-222015-08-24Methods and reagents for prevention and/or treatment of infectionSG11201806985WA (en)

Applications Claiming Priority (2)

Application NumberPriority DateFiling DateTitle
EP14382324.3AEP2987503A1 (en)2014-08-222014-08-22Methods and reagents for prevention and/or treatment of infection
PCT/EP2015/069334WO2016026981A1 (en)2014-08-222015-08-24Methods and reagents for prevention and/or treatment of infection

Publications (1)

Publication NumberPublication Date
SG11201806985WAtrue SG11201806985WA (en)2018-09-27

Family

ID=51485539

Family Applications (1)

Application NumberTitlePriority DateFiling Date
SG11201806985WASG11201806985WA (en)2014-08-222015-08-24Methods and reagents for prevention and/or treatment of infection

Country Status (12)

CountryLink
EP (2)EP2987503A1 (en)
JP (1)JP6612346B2 (en)
KR (1)KR102492850B1 (en)
CN (1)CN107073020B (en)
AU (1)AU2015305108B2 (en)
CA (1)CA2958600C (en)
ES (1)ES2759565T3 (en)
MX (1)MX378754B (en)
PL (1)PL3183003T3 (en)
RU (1)RU2698099C2 (en)
SG (1)SG11201806985WA (en)
WO (1)WO2016026981A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
AU2018365250B2 (en)2017-11-102022-05-26The Johns Hopkins UniversityDendrimer delivery system and methods of use thereof
CN108646029B (en)*2018-05-142021-07-02中国食品药品检定研究院 Human anti-Gal-IgG antibody detection kit and preparation method and use thereof
EP3832762B1 (en)*2018-07-312025-09-24Sumitomo Metal Mining Co., Ltd.Positive electrode active material for lithium ion secondary battery, method for producing positive electrode active material for lithium ion secondary battery, and lithium ion secondary battery
EP3964235A1 (en)*2020-09-082022-03-09RemAb Therapeutics SLGlycoconjugates and medical uses thereof
CN116515102B (en)*2022-01-212025-04-18苏州万维生命科学技术有限公司 Star-shaped β-antibacterial glycopeptide, preparation method and application thereof
WO2023138211A1 (en)*2022-01-212023-07-27苏州万维生命科学技术有限公司STAR-SHAPED β-ANTIBACTERIAL GLYCOPEPTIDE, PREPARATION METHOD THEREFOR AND USE THEREOF
US20240123420A1 (en)*2022-10-122024-04-18Kelly NicholsonFurnace for endothermic processes
US20250180587A1 (en)*2022-10-182025-06-05Tianjin Dexiang Biotechnology Co., LtdApplication of blood group antigen trisaccharide conjugates in the detection of blood group antibodies

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
DK131083A (en)*1982-03-231983-09-24Svenska Sockerfabriks Ab PROCEDURE FOR THE PREPARATION OF THERAPEUTIC OR DIAGNOSTIC PREPARATIONS
US5262165A (en)1992-02-041993-11-16Schering CorporationTransdermal nitroglycerin patch with penetration enhancers
US6010715A (en)1992-04-012000-01-04Bertek, Inc.Transdermal patch incorporating a polymer film incorporated with an active agent
AUPM623994A0 (en)*1994-06-151994-07-07Biomolecular Research Institute LimitedAntiviral dendrimers
JP3534775B2 (en)1995-06-072004-06-07オーソ―マクニール ファーマシューティカル,インコーポレイテッド Transdermal patches and methods for administering 17-deacetylnorgestimate alone or in combination with estrogens
ATE332918T1 (en)*1997-04-182006-08-15Novartis Pharma Gmbh NEOGLYCOPROTEINS
US5948433A (en)1997-08-211999-09-07Bertek, Inc.Transdermal patch
AU761831B2 (en)*1998-04-152003-06-12Bioscience 2002 LlcInhibition of xenoreactive antibodies
CN1395579A (en)*2000-01-132003-02-05阿尔开密亚有限公司Method for synthesis of alpha-D-GA (1-3) GAL-containing oligosaccharides
AU2004209457A1 (en)*2003-02-062004-08-19Tripep AbAntigen/antibody or ligand/receptor glycosylated specificity exchangers
AU2003901008A0 (en)2003-03-042003-03-20Anadis LtdComposition for the treatment and prevention of bacterial infections
US7915235B2 (en)*2006-03-202011-03-29Brian DieckgraefeHigh affinity ligands bind to clostridium difficile toxin A
US8361441B2 (en)2008-03-112013-01-29Taipei Medical UniversityDetection and therapy of bacterial infection caused by Enterobacteriaceae
US7928077B2 (en)*2008-07-112011-04-19Academia SinicaAlpha-galactosyl ceramide analogs and their use as immunotherapies

Also Published As

Publication numberPublication date
EP2987503A1 (en)2016-02-24
AU2015305108B2 (en)2021-03-18
CA2958600A1 (en)2016-02-25
KR20170043556A (en)2017-04-21
MX378754B (en)2025-03-10
RU2698099C2 (en)2019-08-22
PL3183003T3 (en)2020-03-31
MX2017002385A (en)2017-06-30
RU2017108569A (en)2018-09-24
AU2015305108A1 (en)2017-04-06
WO2016026981A1 (en)2016-02-25
RU2017108569A3 (en)2019-03-13
JP6612346B2 (en)2019-11-27
CN107073020A (en)2017-08-18
KR102492850B1 (en)2023-01-26
ES2759565T3 (en)2020-05-11
EP3183003B1 (en)2019-07-31
CA2958600C (en)2023-01-10
EP3183003A1 (en)2017-06-28
JP2017525763A (en)2017-09-07
CN107073020B (en)2019-12-10

Similar Documents

PublicationPublication DateTitle
SG11201806985WA (en)Methods and reagents for prevention and/or treatment of infection
SG11201907034PA (en)Methods of treating influenza
SG11201909963YA (en)Methods for treating dravet syndrome
SG11201906431UA (en)Method for the treatment of thromboembolism
SG11201804312RA (en)Microbubble-chemotherapeutic agent complex for sonodynamic therapy
SG11201407340YA (en)Treatment of myelosuppression
SG11201808539WA (en)Mouth piece for cooling of oral tissue of a patient during chemotherapy treatment
SG11201803686UA (en)Prodrugs of a jak inhibitor compound for treatment of gastrointestinal inflammatory disease
SG11201806868TA (en)Compositions and methods for protecting against airborne pathogens and irritants
SG11201807809XA (en)A transient commensal microorganism for improving gut health
SG11201806845VA (en)Moisturizing compositions and uses thereof
SG11201808222RA (en)Methods of treatment of cholestatic diseases
SG11201811019TA (en)Device for cardiac valve repair and method of implanting the same
SG11201811432WA (en)Rna for cancer therapy
SG11201807913XA (en)Stabilized soluble pre-fusion rsv f proteins
SG11201408459VA (en)Purification of virus like particles
SG11201810280YA (en)Spiro-lactam nmda receptor modulators and uses thereof
SG11201809908TA (en)Stabilized glycopeptide antibiotic formulations
SG11201901374WA (en)Antibiotic compounds
SG11201810454YA (en)Use of an anti-pd-1 antibody in combination with an anti-cd30 antibody in lymphoma treatment
SG11201900021PA (en)Methods and compositions for the treatment of cancer
SG11201906436VA (en)Novel heterocyclic compound, its preparation method, and pharmaceutical composition comprising the same
SG11201900551WA (en)Spiro-lactam nmda receptor modulators and uses thereof
SG11201407110QA (en)Novel dosage form and formulation of abediterol
SG11201407536UA (en)Topical pharmaceutical compositions comprising terbinafine and urea

[8]ページ先頭

©2009-2025 Movatter.jp